1. Home
  2. INVH vs MEDP Comparison

INVH vs MEDP Comparison

Compare INVH & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invitation Homes Inc.

INVH

Invitation Homes Inc.

HOLD

Current Price

$29.78

Market Cap

16.2B

Sector

Finance

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$601.38

Market Cap

15.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVH
MEDP
Founded
2012
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2B
15.4B
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
INVH
MEDP
Price
$29.78
$601.38
Analyst Decision
Buy
Hold
Analyst Count
18
12
Target Price
$32.50
$473.17
AVG Volume (30 Days)
4.0M
344.2K
Earning Date
04-29-2026
04-22-2026
Dividend Yield
4.28%
N/A
EPS Growth
29.73
20.98
EPS
0.26
8.53
Revenue
$2,729,296,000.00
N/A
Revenue This Year
$2.92
$13.19
Revenue Next Year
$2.43
$7.75
P/E Ratio
$113.23
$141.55
Revenue Growth
4.21
N/A
52 Week Low
$24.25
$373.00
52 Week High
$32.05
$677.90

Technical Indicators

Market Signals
Indicator
INVH
MEDP
Relative Strength Index (RSI) 50.03 76.05
Support Level $29.29 $577.01
Resistance Level $30.12 $622.32
Average True Range (ATR) 0.52 20.81
MACD -0.09 3.71
Stochastic Oscillator 30.80 58.12

Price Performance

Historical Comparison
INVH
MEDP

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: